Glazer Capital’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
HP
Glazer Capital's DALS Position: Q4 2021 in Review
Glazer Capital sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q4 2021, closing a stake of 21,990 shares — an estimated $216K sold.
Glazer Capital first reported a position in DALS in Q3 2021 and held it in 1 quarter. The position peaked at $216K in Q3 2021. 36 funds tracked by Wall St. Rank hold DALS as of Q4 2021.
- Glazer Capital reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q4 2021 after selling out during the quarter.
- Glazer Capital sold 21,990 DA32 Life Science Tech Acquisition Corp shares in Q4 2021, an estimated $216K.
- Glazer Capital first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 1 quarter.
- Glazer Capital's DA32 Life Science Tech Acquisition Corp position peaked at $216K in Q3 2021.
- 36 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q4 2021.
Based on Glazer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.